Inhibition of Zinc-Dependent Peptidases by Maillard Reaction Products

Total Page:16

File Type:pdf, Size:1020Kb

Inhibition of Zinc-Dependent Peptidases by Maillard Reaction Products Inhibition of zinc-dependent peptidases by Maillard reaction products DISSERTATION zur Erlangung des akademischen Grades Doktor rerum naturalium (Dr. rer. nat.) vorgelegt der Fakultät Mathematik und Naturwissenschaften der Technischen Universität Dresden von Leticia Missagia de Marco geboren am 23. März 1978 in Belo Horizonte, Brasilien Eingereicht am: 09.10.2014 Verteidigt am: 09.03.2015 Die Dissertation wurde in der Zeit von April 2005 bis Dezember 2011 an der Professur für Lebensmittelchemie angefertigt. List of Contents List of Contents LIST OF CONTENTS .............................................................................................................. I LIST OF TABLES ................................................................................................................. IV LIST OF FIGURES ................................................................................................................. V LIST OF ABBREVIATIONS .............................................................................................. VII 1 INTRODUCTION ............................................................................................................ 1 2 BACKGROUND ............................................................................................................... 3 2.1 Maillard reaction in food ................................................................................................. 3 2.1.1 Melanoidins .................................................................................................................... 8 2.2 Coffee ............................................................................................................................... 11 2.2.1 General aspects ............................................................................................................ 11 2.2.1.1 Coffee production .................................................................................................... 12 2.2.1.2 General chemical composition ................................................................................ 14 2.2.1.3 Coffee and health .................................................................................................... 20 2.2.2 Coffee melanoidins ...................................................................................................... 24 2.2.2.1 Chemistry of coffee melanoidins ............................................................................ 24 2.2.2.2 Properties of coffee melanoidins ............................................................................. 29 2.3 Zinc metallopeptidases ................................................................................................... 32 2.3.1 Matrix metalloproteinases (MMPs) ............................................................................. 33 2.3.1.1 Functions of MMPs ................................................................................................. 35 2.3.1.2 Structure of MMPs .................................................................................................. 37 2.3.1.3 Inhibition of MMPs ................................................................................................. 39 2.3.2 Clostridium histolyticum collagenase (ChC) ............................................................... 43 2.3.2.1 Functions of ChC .................................................................................................... 43 2.3.2.2 Structure of ChC ..................................................................................................... 43 2.3.2.3 Inhibition of ChC .................................................................................................... 44 2.3.3 Agiotensin converting enzyme (ACE) ......................................................................... 45 2.3.3.1 Functions of ACE .................................................................................................... 45 2.3.3.2 Structure of ACE ..................................................................................................... 46 2.3.3.3 Inhibition of ACE .................................................................................................... 48 3 EXPERIMENTAL SECTION ....................................................................................... 50 3.1 Chemicals, materials and equipment ............................................................................ 50 3.1.1 Chemicals ..................................................................................................................... 50 3.1.2 Material ........................................................................................................................ 52 3.1.3 Equipment .................................................................................................................... 52 3.1.4 Solutions....................................................................................................................... 54 I List of Contents 3.2 Synthesis of Nα-carboxyalkylated peptides ................................................................... 55 3.2.1 Nα-carboxyalkylation of GP, LL, IA, GA, GL, AP, IP and IPP by reductive alkylation ............................................................................................................................................... 55 3.2.2 Nα-carboxyalkylation of IW using sodium cyanoborohydride .................................... 56 3.3 Purification ...................................................................................................................... 57 3.3.1 Ion Exchange Chromatographic purification ............................................................... 57 3.3.1.1 Spotting test ............................................................................................................. 58 3.3.2 HPLC purification of CM-IW ...................................................................................... 58 3.3.3 Overview of the synthesis and elution conditions ....................................................... 59 3.4 Characterization of carboxyalkylated peptides ........................................................... 61 3.4.1 Mass spectrometry ....................................................................................................... 61 3.4.2 Elemental Analysis ...................................................................................................... 61 3.4.3 Analytical characteristics of carboxyalkylated peptides .............................................. 62 3.5 Preparation of coffee fractions ...................................................................................... 65 3.5.1 Roasting conditions ...................................................................................................... 65 3.5.2 Fractionation of coffee samples: Isolation of coffee melanoidins ............................... 67 3.6 Structural studies ............................................................................................................ 69 3.6.1 Estimation of the molecular weight ............................................................................. 69 3.6.2 C/N ratio ....................................................................................................................... 70 3.6.3 Amino acid analysis ..................................................................................................... 70 3.6.3.1 Acid hydrolysis ....................................................................................................... 70 3.6.3.2 General amino acid analysis .................................................................................... 70 3.6.3.3 Lysinoalanine .......................................................................................................... 71 3.6.3.4 Pentosidine .............................................................................................................. 72 3.6.4 Total phenols ................................................................................................................ 74 3.6.5 Raman spectroscopy .................................................................................................... 74 3.7 Study on inhibition of zinc metalloproteases ................................................................ 75 3.7.1 Inhibition of ACE......................................................................................................... 75 3.7.1.1 General enzymatic assay ......................................................................................... 75 3.7.1.2 Quantification .......................................................................................................... 78 3.7.2 Inhibition of MMP-1, -2 and -9 ................................................................................... 79 3.7.2.1 General enzymatic assay ......................................................................................... 80 3.7.2.2 Effect of zinc addition on the inhibition of MMP-1 by melanoidins ...................... 81 3.7.3 Inhibition of ChC ......................................................................................................... 82 3.7.3.1 General enzymatic assay ......................................................................................... 82 3.7.3.2 Quantification .......................................................................................................... 84 3.7.4 Calculation of IC50 ......................................................................................................
Recommended publications
  • Metalloproteases): a Review
    Accepted Manuscript Therapeutic applications of collagenase (metalloproteases): A review Hamzeh Alipour, Abbasali Raz, Sedigheh Zakeri, Navid Dinparast Djadid PII: S2221-1691(16)30793-6 DOI: 10.1016/j.apjtb.2016.07.017 Reference: APJTB 369 To appear in: Asian Pacific Journal of Tropical Biomedicine Received Date: 14 February 2016 Revised Date: 27 February 2016 Accepted Date: 27 July 2016 Please cite this article as: Alipour H, Raz A, Zakeri S, Djadid ND, Therapeutic applications of collagenase (metalloproteases): A review, Asian Pacific Journal of Tropical Biomedicine (2016), doi: 10.1016/j.apjtb.2016.07.017. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ACCEPTED MANUSCRIPT Title: Therapeutic applications of collagenase (metalloproteases): A review Authors: Hamzeh Alipour 1,2,# , Abbasali Raz 1,# , Sedigheh Zakeri 1, Navid Dinparast Djadid 1* Affiliations: 1Malaria and Vector Research Group, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran 2Department of Medical Entomology, School of Health, Research Center for Health Sciences, Shiraz University of Medical Sciences, Shiraz, Iran Keywords: Enzyme Therapeutic application Collagenase MANUSCRIPT Non-invasive Metalloproteinase *Corresponding author: Navid Dinparast Djadid, Malaria and Vector Research Group, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. Tel: +91 23573763 E-mail: [email protected] Foundation Project: Supported by Pasteur Institute of Iran and Iran National Science Foundation (Grant No.
    [Show full text]
  • Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis
    International Journal of Molecular Sciences Review Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis David Johane Machate 1, Priscila Silva Figueiredo 2 , Gabriela Marcelino 2 , Rita de Cássia Avellaneda Guimarães 2,*, Priscila Aiko Hiane 2 , Danielle Bogo 2, Verônica Assalin Zorgetto Pinheiro 2, Lincoln Carlos Silva de Oliveira 3 and Arnildo Pott 1 1 Graduate Program in Biotechnology and Biodiversity in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] (D.J.M.); [email protected] (A.P.) 2 Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; pri.fi[email protected] (P.S.F.); [email protected] (G.M.); [email protected] (P.A.H.); [email protected] (D.B.); [email protected] (V.A.Z.P.) 3 Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-67-3345-7416 Received: 9 March 2020; Accepted: 27 March 2020; Published: 8 June 2020 Abstract: Long-term high-fat dietary intake plays a crucial role in the composition of gut microbiota in animal models and human subjects, which affect directly short-chain fatty acid (SCFA) production and host health. This review aims to highlight the interplay of fatty acid (FA) intake and gut microbiota composition and its interaction with hosts in health promotion and obesity prevention and its related metabolic dysbiosis.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2008/0305517 A1 Griffin Et Al
    US 2008O305517A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0305517 A1 Griffin et al. (43) Pub. Date: Dec. 11, 2008 (54) TRANSGLUTAMINASE CROSSLINKED (30) Foreign Application Priority Data COLLAGEN BOMATERAL FOR MEDICAL MPLANT MATERALS Sep. 10, 2004 (GB) ................................... O42O091.1 (75) Inventors: Martin Griffin, Nottingham (GB); Publication Classification Russell Collighan, Birmingham (51) Int. Cl. (GB); David Chau, Birmingham CI2N 5/06 (2006.01) (GB); Elisabetta Verderio CI2P 2L/02 (2006.01) Edwards, Nottingham (GB) A6IF 2/28 (2006.01) A6F I3/00 (2006.01) Correspondence Address: FSH & RICHARDSON PC (52) U.S. Cl. ..................... 435/68.1; 435/395; 623/16.11; 602/48 P.O. BOX 1022 MINNEAPOLIS, MN 55440-1022 (US) (57) ABSTRACT (73) Assignee: ASTON UNIVERSITY, The present invention provides a method for producing an Birmingham, West Midlands (GB) improved biomaterial comprising treating a collagen bioma terial with a transglutaminase under conditions which permit (21) Appl. No.: 111574,918 the formation of cross-links within the collagen. Preferably, the transglutaminase is a tissue transglutaminase, a plasma (22) PCT Filed: Sep. 12, 2005 transglutaminase or a microbial transglutaminase. In a pre ferred embodiment, the collagen biomaterial further com (86). PCT No.: PCT/GBOS/O352O prises a cell adhesion factor, Such as fibronectin. The inven tion further provides biomaterials obtainable by the methods S371 (c)(1), of the invention, and medical implants and wound dressings (2), (4) Date: Aug. 11, 2008 comprising the same. -- Collagen (3 mg/ml) -O- Coll-mTG (50ug/ml) -v- Co-mTG (250ug/ml) -v- Coll-mTG-R281 -- Coll-R281 O 5 10 15 20 25 Time (min) Patent Application Publication Dec.
    [Show full text]
  • Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease
    pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health Published online September 6, 2017 https://doi.org/10.5534/wjmh.17033 Review Article Collagenase Clostridium Histolyticum in the Treatment of Peyronie’s Disease: Review of a Minimally Invasive Treatment Option Andrew T Gabrielson, Laith M Alzweri, Wayne JG Hellstrom Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA Peyronie’s disease (PD) is an inflammatory disorder characterized by an abnormal collagen deposition in the tunica albuginea of the penis, leading to fibrous and non-compliant plaques that can impede normal erection. Although pharmacological treatments are available, only intralesional injection therapy and surgical reconstruction have demonstrated tangible clinical efficacy in the management of this condition. Intralesional injection of collagenase clostridium histolyticum (CCH) has come to the forefront of minimally invasive treatment of PD. In this review, the authors provide an update on the safety, efficacy, and indications for CCH. The efficacy of CCH will be assessed on the basis of improvement in the severity of penile fibrosis, curvature, and pain. Numerous well-designed clinical trials and post-approval studies involving more than 1,500 patients have consistently demonstrated the efficacy and tolerability of CCH in the treatment of PD. CCH significantly decreases penile curvature and plaque consistency, as well as improves quality of life. Post-approval studies continue to demonstrate the efficacy of CCH despite broader inclusion criteria for treatment, such as the case with acute phase disease and atypical plaque deformities (i.e., ventral plaques, hourglass narrowing). CCH continues to be the gold standard for non-surgical management of stable phase PD, in the absence of strong evidence supporting oral therapy agents and ongoing evaluation of extracorporeal shockwave therapy.
    [Show full text]
  • Optimization of Enzyme Dissociation Process Based On
    OPTIMIZATION OF ENZYME DISSOCIATION PROCESS BASED ON REACTION DIFFUSION MODEL TO PREDICT TIME OF TISSUE DIGESTION DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Bhavya Mehta, B.E. ***** The Ohio State University 2006 Dissertation Committee: Dr. Jeffrey J. Chalmers Approved By Dr. David L. Tomasko Dr. Deborah M. Grzybowski ------------------------------------------------------ Adviser Chemical Engineering Graduate Program ABSTRACT With the advent and improvement of highly sensitive and accurate molecular analysis technologies, it is possible to study increasingly complex cellular processes. These technologies have played a significant role in cancer diagnosis. However, a common complaint of studies using these technologies is the heterogeneity of the original sample. The lack of homogeneity is a challenge when one works with non-cultured, three-dimensional tissue, which normally consists of a variety of different cell types, in different states. Therefore, the ability to analyze and separate a heterogeneous cell population based on cellular characteristics is a significant analytical and preparative resource for molecular analysis techniques. The sample preparation techniques in case of a tissue sample are rudimentary and opportunities are ample. The cellular components of a tissue sample are bonded tightly together by extracellular material (ECM). The main components of ECM are proteins (collagen and elastin), which are broken down using enzymes such as collagenase, elastase, metalloproteinases etc. The enzyme dissociation process is an integral part of life sciences laboratory and is designed predominantly based on empirical experience of each research group. There is little or no fundamental understanding available about the enzyme dissociation process to produce single cell suspension from a tissue.
    [Show full text]
  • Structural, Functional and Therapeutic Aspects of Snake Venom Metal- Loproteinases
    Send Orders for Reprints to [email protected] 28 Mini-Reviews in Organic Chemistry, 2014, 11, 28-44 Structural, Functional and Therapeutic Aspects of Snake Venom Metal- loproteinases P. Chellapandi* Department of Bioinformatics, School of Life Sciences, Bharathidasan University, Tiruchirappalli-620024, Tamil Nadu, India Abstract: Snake venoms are rich sources of metalloproteinases that are of biological interest due to their diverse molecu- lar diversity and selective therapeutic applications. Snake venoms metalloproteinases (SVMPs) belong to the MEROPS peptidase family M12B or reprolysin subfamily, which are consisted of four major domains include a reprolysin catalytic domain, a disintegrin domain, a reprolysin family propeptide domain and a cysteine-rich domain. The appropriate struc- tural and massive sequences information have been available for SVMPs family of enzymes in the Protein Data Bank and National Center for Biotechnology Information, respectively. Functional essentiality of every domain and a crucial contri- bution of binding geometry, primary specificity site, and structural motifs have been studied in details, pointing the way for designing potential anti-coagulation, antitumor, anti-complementary and anti-inflammatory drugs or peptides. These enzymes have been reported to degrade fibrinogen, fibrin and collagens, and to prevent progression of clot formation. An- giotensin-converting enzyme activity, antibacterial properties, haemorrhagic activity and platelet aggregation response of SVMPs have been studied earlier. Structural information of these enzymes together with recombinant DNA technology would strongly promote the construction of many recombinant therapeutic peptides, particularly fibrinogenases and vac- cines. We have comprehensively reviewed the structure-function-evolution relationships of SVMPs family proteins and their advances in the promising target models for structure-based inhibitors and peptides design.
    [Show full text]
  • Supplemental Table 1: Taxa by Symptom Taxonomy Browser Https
    Supplemental table 1: Taxa by Symptom Taxonomy Browser https://www.ncbi.nlm.nih.gov/taxonomy ↑= Enriched (X) = study number ↓= Decreased Taxa reference Phylum Class Order Family Genus Species Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium Bifidobacterium infantis Actinomyces Coriobacteriia Coriobacteriales Coriobacteriaceae Eggerthella Eggerthella lenta Bacteriodetes Bacteriodia Bacteriodales Bacteroidaceae Bacteroides Bacteroides fragilis Muribaculaceae Prevotellaceae Prevotella Rikenellaceae Acetobacteroides Alistipes Rikenella Tannerellaceae Parabacteroides Porphyromonadaceae Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus Enterococcaceae Enterococcus Dehalobacterium Streptococcaceae Streptococcus Streptococcus anginosus Lactococcus Clostridia Clostridiales Clostridiaceae Clostridium Clostridium histolyticum Hungatella Peptostreptococcaceae Intestinibacter Terrisporobacter Lachnospiraceae Anaerostipes Coprococcus Dorea Lachnospira Roseburia Lachnoclostridium Taxa reference Phylum Class Order Family Genus Species Tyzzerella Oscillospiraceae Oscillibacter Ruminococcaceae Faecalibacterium Ruminococcus Caproiciproducens Oscillospira Anaerotruncus Erysipelotrichia Erysipelotrichales Erysipelotrichaceae Holdemania Coprobacillus Negativicutes Acidaminococcales Acidaminococcaceae Vellionellales Vellonellaceae Veillonella Dialister Tissierellia Tissierellales Peptoniphilaceae Anaerococcus Proteobacteria Betaproteobacteria Betaproteobacteriales Burkholderiales Burkholderiaceae Sutterellaceae
    [Show full text]
  • Association of Moderate Beer Consumption with the Gut Microbiota and SCFA of Healthy Adults
    molecules Article Association of Moderate Beer Consumption with the Gut Microbiota and SCFA of Healthy Adults Natalia González-Zancada, Noemí Redondo-Useros, Ligia E. Díaz, Sonia Gómez-Martínez , Ascensión Marcos and Esther Nova * Immunonutrition Group, Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN), Spanish National Research Council (CSIC), C/Jose Antonio Novais, 28040 Madrid, Spain; [email protected] (N.G.-Z.); [email protected] (N.R.-U.); [email protected] (L.E.D.); [email protected] (S.G.-M.); [email protected] (A.M.) * Correspondence: [email protected]; Tel.: +34-915492300 Received: 30 September 2020; Accepted: 15 October 2020; Published: 17 October 2020 Abstract: Fermented alcoholic drinks’ contribution to the gut microbiota composition is mostly unknown. However, intestinal microorganisms can use compounds present in beer. This work explored the associations between moderate consumption of beer, microbiota composition, and short chain fatty acid (SCFA) profile. Seventy eight subjects were selected from a 261 healthy adult cohort on the basis of their alcohol consumption pattern. Two groups were compared: (1) abstainers or occasional consumption (ABS) (n = 44; <1.5 alcohol g/day), and (2) beer consumption 70% of total ≥ alcohol (BEER) (n = 34; 200 to 600 mL 5% vol. beer/day; <15 mL 13% vol. wine/day; <15 mL 40% vol. spirits/day). Gut microbiota composition (16S rRNA gene sequencing) and SCFA concentration were analyzed in fecal samples. No differences were found in α and β diversity between groups. The relative abundance of gut bacteria showed that Clostridiaceae was lower (p = 0.009), while Blautia and Pseudobutyrivibrio were higher (p = 0.044 and p = 0.037, respectively) in BEER versus ABS.
    [Show full text]
  • Clostridium Sordelli As a Cause of Gas Gangrene in a Trauma Patient Vijeta Bajpai, Aishwarya Govindaswamy, Sonu Kumari Agrawal1, Rajesh Malhotra2, Purva Mathur
    Published online: 2020-04-06 Case Report Access this article online Quick Response Code: Clostridium sordelli as a cause of gas gangrene in a trauma patient Vijeta Bajpai, Aishwarya Govindaswamy, Sonu Kumari Agrawal1, Rajesh Malhotra2, Purva Mathur Website: www.jlponline.org Abstract: DOI: Gas gangrene is a necrotic infection of the skin and soft tissue that is associated with high mortality 10.4103/JLP.JLP_108_18 and often necessitating amputation to control the infection. Clostridial myonecrosis is most often cause of gas gangrene and usually present in settings of trauma, surgery, malignancy, and other underlying immunocompromised conditions. The most common causative organism of clostridial myonecrosis is Clostridium perfringens followed by Clostridium septicum. Here, we are reporting an unusual case report of posttraumatic gas gangrene caused by Clostridium sordelli. Key words: Clostridium sordelli, matrix‑assisted laser desorption/Ionization‑time‑of‑flight, myonecrosis, trauma Introduction Case Report lostridium sordellii is an anaerobic A 32‑year‑old male patient presented to the CGram‑positive bacillus with subterminal emergency department of trauma center spores and peritrichous flagella. It is with a fracture of the right sacroiliac joint commonly not only found in the soil and along with open wound of right tibial sewage but also as part of the normal fracture. Elective surgery was performed flora of the gastrointestinal tract and for sacroiliac disruption and pubic vagina of a small percentage of healthy diastasis. Three days after surgery, the individuals.[1] Although most strains patient developed toxic symptoms such of C. sordellii are nonpathogenic, some as high‑grade fever (102°F), tachycardia, virulent, toxin‑producing strains cause and hypotension.
    [Show full text]
  • Collagen (Obtained from Acellular Maûix (ACM) Processed Arteries) and 'Purified' Type 1 Collagen (Extracted from Bovine Achilles Tendon) Was Studied
    The Effect of Chemical Modification on the Enzymatic Degradation of Acellular Matrix (ACM) Processed Biomaterials Paul F. Gratzer A thesis submitted in canformity with the requirements for the degree of Dodor of Philosophy Graduate Departmentof Metallurgyand Materials Scienœ Engineering and the Institute of Biomaterialsand Biomedical Engineering University of Toronto O Copyright by Paul F. Gratzer 1999 National Library Bibliothèque nationale l*! of Canada du Canada Acquisitions and Acquisitions et Bibiiographic Services services bibliographiques 395 Wellington Street 395. rue Wellington OtlawaOfU K1AW OttawaON KlAûN4 Canada CaMda The author has granted a non- L'auteur a accordé une licence non exclusive licence allowing the exclusive permettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or sell reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfiche/nlm, de reproduction sur papier ou sur fcmat électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fiom it Ni la thèse ni des extraits substantiels may be prhted or otherwise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. The Effect of Chemical Modification on the Enzymatic Degradation of Acellular Matrix (ACM) Processed Biomaterials Paul F. Gratzer Doctor of Philosophy, 1999 Department of Metallurgy and Materials Science and lnstitute of Biomaterials and Biomedical Engineering, University of Toronto In this study, the effects of specific chemical modifications of amino add side- chains on the in vitro degradation of 'native' collagen (obtained from acellular maûix (ACM) processed arteries) and 'purified' type 1 collagen (extracted from bovine Achilles tendon) was studied.
    [Show full text]
  • Recombinant Expression and Functional Analysis of Proteases from Streptococcus Pneumoniae, Bacillus Anthracis, and Yersinia Pestis
    Kwon et al. BMC Biochemistry 2011, 12:17 http://www.biomedcentral.com/1471-2091/12/17 RESEARCHARTICLE Open Access Recombinant expression and functional analysis of proteases from Streptococcus pneumoniae, Bacillus anthracis, and Yersinia pestis Keehwan Kwon, Jeremy Hasseman, Saeeda Latham, Carissa Grose, Yu Do, Robert D Fleischmann, Rembert Pieper and Scott N Peterson* Abstract Background: Uncharacterized proteases naturally expressed by bacterial pathogens represents important topic in infectious disease research, because these enzymes may have critical roles in pathogenicity and cell physiology. It has been observed that cloning, expression and purification of proteases often fail due to their catalytic functions which, in turn, cause toxicity in the E. coli heterologous host. Results: In order to address this problem systematically, a modified pipeline of our high-throughput protein expression and purification platform was developed. This included the use of a specific E. coli strain, BL21(DE3) pLysS to tightly control the expression of recombinant proteins and various expression vectors encoding fusion proteins to enhance recombinant protein solubility. Proteases fused to large fusion protein domains, maltosebinding protein (MBP), SP-MBP which contains signal peptide at the N-terminus of MBP, disulfide oxidoreductase (DsbA) and Glutathione S-transferase (GST) improved expression and solubility of proteases. Overall, 86.1% of selected protease genes including hypothetical proteins were expressed and purified using a combination of five different expression vectors. To detect novel proteolytic activities, zymography and fluorescence-based assays were performed and the protease activities of more than 46% of purified proteases and 40% of hypothetical proteins that were predicted to be proteases were confirmed. Conclusions: Multiple expression vectors, employing distinct fusion tags in a high throughput pipeline increased overall success rates in expression, solubility and purification of proteases.
    [Show full text]